To assess the clinical utility of neuronal and glial apoptotic bodies (CNS-ApBs) as in vivo markers of activation of apoptotic processes during stroke, Spearman correlation analysis was performed between plasma CNS-ApB levels at the three time points tested after the stroke and infarct expansion. The gene discussed is RNPEP; the disease is stroke disorder.